StockData
BDTBOTCServices-Management Consulting ServicesFiscal year ends September 30

Bodhi Tree Biotechnology Inc

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.28+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$7.17M
P/E (TTM)
–
Dividend yield
–

About Bodhi Tree Biotechnology

Services-Management Consulting Services, SIC 8742

Bodhi Tree Biotechnology Inc. is an early-stage consulting company that specializes in vegetarian and plant-based nutrition services. The company designs customized vegetarian menus and develops plant-based recipes with distinctive flavor profiles for clients seeking healthier and more sustainable food choices. In addition to culinary recipe formulation, it provides vegetarian dietary consulting, which includes nutritional assessments, ingredient sourcing analysis, dietary trend research, and general planning support. Bodhi Tree offers both in-person and online consulting services on a project basis. Its target customers comprise individual consumers pursuing vegetarian, flexitarian, and organic diets.

The company conducts its operations primarily within the United States through direct sales channels. Its corporate executive office is located in Danville, California, and it does not own or lease commercial office space. As an emerging enterprise, the company maintains minimal physical infrastructure and employs no full-time staff other than its executive officers. Management directly handles day-to-day business operations and maintains an informational website.

Summary of the business section of Bodhi Tree Biotechnology's latest annual report, written by StockData.

Company profile

Company

Legal name
Bodhi Tree Biotechnology Inc
Founded
2023
Headquarters
Danville, CA
Address
4125 Blackhawk Plaza Circle, Suite 172 94506
Phone
(925) 406-4528
Industry
Services-Management Consulting Services
Incorporated in
Delaware
Fiscal year ends
September 30
Auditor
Simon & Edward, LLP, Rowland Heights, CA

Stock & identifiers

Ticker
BDTB
Exchange
OTC
Shares outstanding
25M, Aug 14, 2026
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
2041531
EIN
93-4908449

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Bodhi Tree Biotechnology's leadership is listed in its proxy statement (Form DEF 14A).

Corporate history

Events identified from SEC filings

DateEventDetails
May 14, 2025Late filingNotification of late filing